General
Long-term, low-dose aspirin has little impact on CVD risk in T2D
 

Long-term, low-dose aspirin has little impact on CVD risk in T2D

Shared by:

 
Long-term, low-dose aspirin does not affect the risk of cardiovascular disease (CVD) in individuals with type 2 diabetes (T2D), according to findings of the JPAD2* study.
 
specialty.mims.com
 
8 Dec 2016 - General
 
It is a wondering news to hear because once a person gets diagnosed to have a cardio vascular accident or once a person is having a high risk of having it physicians prescribe aspirin as a preventive measure since it interferes platelet function and ...
 (Total 56 words)
A recent study finding has shown that low-dose aspirin did not appear to reduce the incidence of CVD in patients with T2D even after adjusting for age, sex, glycemic control, kidney function, smoking status, hypertension, and dyslipidemia. It is obvi...
 (Total 61 words)